{"id":"W2327416432","doi":"10.1016/j.jcjd.2014.07.159","title":"Efficacy and Safety of Empagliflozin (EMPA) in Younger, Overweight/Obese Patients with Type 2 Diabetes (T2DM) with HbA1c ≥8%","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Empagliflozin; EMPA; Medicine; Overweight; Placebo; Obesity; Internal medicine; Type 2 diabetes; Body mass index; Diabetes mellitus; Post-hoc analysis; Endocrinology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000771566,0.0002311071,0.001100105,0.0002179144,0.0002134554,0.0004072906,0.0001382401,0.0004496698,0.001333375],"category_scores_gemma":[0.001579101,0.0001903703,0.0008821024,0.000268945,0.000233401,0.0006327276,0.0002182364,0.001249695,0.0002038273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003878786,"about_ca_system_score_gemma":0.0003934797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001177276,"about_ca_topic_score_gemma":0.00149783,"domain_scores_codex":[0.9998067,0.00004240765,0.00002662538,0.00003932835,0.00004876624,0.00003630257],"domain_scores_gemma":[0.9993788,0.00018706,0.0001553418,0.00003175957,0.00003923264,0.0002078273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5683365,0.009428645,0.1740326,0.0005795793,0.001557973,0.0005162563,0.0003060473,0.001090502,0.01583167,0.0001169278,0.001528825,0.2266745],"study_design_scores_gemma":[0.07140644,0.1278524,0.7885095,0.0001561767,0.00272526,0.0009967211,0.0002119745,0.002406555,0.002897045,0.0002088404,0.002561029,0.00006800701],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970175,0.002016149,0.00007150602,0.0001321262,0.0000294349,0.00002717499,0.0001761799,0.000007132877,0.0005227645],"genre_scores_gemma":[0.9977922,0.001140234,0.0001272963,0.0002564758,0.0001066765,0.00003252057,0.0002674047,0.000003288852,0.0002739702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001333375,"threshold_uncertainty_score":0.004460633,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004812209489320978,"score_gpt":0.1886675255404905,"score_spread":0.1838553160511695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}